iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Venlafaxine extended-release tablets and Pregabalin extended-release tablets.

image

Ashok Leyland advanced 3.86% to Rs 159.95 after the auto majors total commercial vehicle (CV) sales jumped 51% to 14,121 units in August 2022 from 9,360 units sold in August 2021.

image

On August 12, it was announced that the Tata Trusts, the largest shareholders in Tata Sons, were seeking legal advice to investigate the possibility of including a clause in the trust deeds prohibiting the same person from leading both the trusts and the holding company Tata Sons while upholding the founders' wishes.

image

On 5 September 2022

image

On August 12, it was announced that the Tata Trusts, the largest shareholders in Tata Sons, were seeking legal advice to investigate the possibility of including a clause in the trust deeds prohibiting the same person from leading both the trusts and the holding company Tata Sons while upholding the founders' wishes

image

On 27 September 2022

image

On 28 September 2022

image

On 30 September 2022

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.